Ward Marlatte - Algae Biosciences Insider

CEO, Secretary and Director

We currently do not have informatin regarding Ward Marlatte. This executive tanure with Algae Biosciences Corporation is not currenlty determined.
  CEO Since 2013      
928-240-1060  http://www.algaebio.com

Management Efficiency

The company has return on total asset (ROA) of (21.6) % which means that it has lost $21.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (51.33) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 346.75 K in total debt with debt to equity ratio (D/E) of 0.17 which may suggest the company is not taking enough advantage from borrowing. Algae Biosciences Corporation has Current Ratio of 0.03 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Filter Other Executives

Entity Summary

Algae Biosciences Corporationration, a development stage biotechnology company, engages in the research, development, manufacture, and sale of micro and macro algae solutions nutraceuticals, food additives, and pharmaceuticals markets in the United States. Algae Biosciences Corporation (AGBCF) is traded on OTC Market in USA. It is located in Scottsdale, AZ and employs 5 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Algae Biosciences Corporation to your portfolio
Top Management
Algae Biosciences Leadership Team
Laurence Luke, Director
Wayne Tinker, Executive
Kevin Blanchette, Director
Anthony Smith, Executive
Jody Stachiw, Director
Ward Marlatte, CEO
Marc Stachiw, Director
Gordon Aldcorn, Director
Stock Performance
Algae Biosciences Performance Indicators